Concepedia

Roy Bannister

RB

Statistics

Publications

32

Citations

5.4K

H-Index

21

Active since

1969

Affiliations

Gilead Sciences (United States)(Current)

University of North Carolina at Chapel Hill

United States Army Medical Research Institute of Infectious Diseases

Texas A&M University

Centers for Disease Control and Prevention

Roy Bannister is an author at Gilead Sciences (United States) specializing in antiviral therapy, virology, and molecular virology.

Publications per year

1969–2025

32

Publications

32

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan, Amy Sims, Rachel L. Graham et al. · Science Translational Medicine · 2017 · 1.6K citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +14

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Travis K. Warren, Robert Jordan, Michael K. Lo et al. · Nature · 2016 · 1.6K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-<i>f</i>][triazin-4-amino] Adenine <i>C</i>-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses

Dustin S. Siegel, Hon C. Hui, Edward Doerffler et al. · Journal of Medicinal Chemistry · 2017 · 665 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge

Michael K. Lo, Friederike Feldmann, Joy Gary et al. · Science Translational Medicine · 2019 · 275 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

Eve‐Irene Lepist, Xuexiang Zhang, Hao Jia et al. · Kidney International · 2014 · 244 citations · Full text

Medicine, Nephrology, Pharmacology +17

1–5 of 32